US BANCORP \DE\ - AMICUS THERAPEUTICS INC ownership

AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 139 filers reported holding AMICUS THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 0.24 and the average weighting 0.3%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of AMICUS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$287,011
-6.0%
23,603
-2.9%
0.00%
Q2 2023$305,321
-16.2%
24,309
-26.1%
0.00%
-100.0%
Q1 2023$364,562
-3.9%
32,873
+5.8%
0.00%0.0%
Q4 2022$379,255
-23.8%
31,061
-34.7%
0.00%0.0%
Q3 2022$498,000
-5.9%
47,559
-3.5%
0.00%0.0%
Q2 2022$529,000
+269.9%
49,292
+227.5%
0.00%
Q1 2022$143,000
+14200.0%
15,049
+16809.0%
0.00%
Q4 2021$1,000
-99.0%
89
-99.2%
0.00%
Q3 2021$104,000
-18.1%
10,907
-17.3%
0.00%
Q2 2021$127,000
+14.4%
13,182
+17.4%
0.00%
Q1 2021$111,000
+1485.7%
11,227
+3408.4%
0.00%
Q4 2020$7,000
+133.3%
320
+53.1%
0.00%
Q3 2020$3,0000.0%2090.0%0.00%
Q2 2020$3,000
-25.0%
209
-51.2%
0.00%
Q1 2020$4,000
-33.3%
428
-29.0%
0.00%
Q4 2019$6,000
-90.2%
603
-87.7%
0.00%
Q2 2019$61,000
+38.6%
4,896
+50.9%
0.00%
Q1 2019$44,000
+528.6%
3,245
+365.6%
0.00%
Q4 2018$7,000
-41.7%
697
-14.4%
0.00%
Q1 2018$12,0000.0%814
-0.4%
0.00%
Q4 2017$12,0000.0%817
+0.5%
0.00%
Q3 2017$12,000813
+1013.7%
0.00%
Q4 2016$0
-100.0%
73
-98.5%
0.00%
Q3 2016$36,000
+38.5%
4,8050.0%0.00%
Q2 2016$26,000
-36.6%
4,8050.0%0.00%
Q1 2016$41,000
-12.8%
4,8050.0%0.00%
Q4 2015$47,000
-29.9%
4,8050.0%0.00%
Q3 2015$67,000
-57.1%
4,805
-56.5%
0.00%
-100.0%
Q2 2015$156,000
+24.8%
11,045
-3.6%
0.00%
Q1 2015$125,000
+16.8%
11,455
-10.8%
0.00%
Q4 2014$107,00012,8450.00%
Other shareholders
AMICUS THERAPEUTICS INC shareholders Q4 2016
NameSharesValueWeighting ↓
Palo Alto Investors LP 10,114,043$116,817,0007.46%
Parametrica Management Ltd 597,279$6,899,0006.86%
Redmile Group, LLC 22,716,086$262,371,0005.96%
Perceptive Advisors 53,118,886$613,524,0004.73%
Asymmetry Capital Management, L.P. 716,709$8,278,0004.39%
CM Management, LLC 450,000$5,198,0003.93%
Avoro Capital Advisors LLC 18,500,000$213,675,0003.64%
Kynam Capital Management, LP 573,699$6,626,0003.54%
SECTORAL ASSET MANAGEMENT INC 1,242,882$14,355,0002.16%
Ghost Tree Capital, LLC 500,000$5,775,0002.07%
View complete list of AMICUS THERAPEUTICS INC shareholders